News

Even as prices drop, it's difficult to keep up with demand for new obesity drugs
Doctors say the situation forces them to get creative in treating patients, but there’s hope that prices may fall more in the ...
BusinessMirror47m
Group slams continued sale of banned underarm whitening cream from Thailand
A mercury-tainted underarm whitening cream continues to be smuggled into the country, imported, distributed, and sold to Filipino consumers despite a public health warning issued by the Food and Drug ...
Pharmaceutical Technology52m
FDA approves KalVista’s Ekterly for hereditary angioedema
The FDA has approved Ekterly (sebetralstat) as the first and only oral on-demand medication for acute attacks of hereditary angioedema (HAE).
Nationwide Gummies Recall Update as FDA Issues Highest Risk Warning
Vita Warehouse Corp. recalled more than 40,000 bottles of Vitamin B12 supplements for possible undeclared presence of peanut.
STAT1h
Inside the staff exodus and tanking morale that threaten Makary’s FDA
WASHINGTON — The steady erosion of experienced staff at the Food and Drug Administration is slowly compromising the agency’s ...
STAT1h
Pharmalittle: We’re reading about FDA morale, a U.S.-Swiss trade deal on pharma levies, and more
The steady erosion of experienced staff is slowly compromising FDA work and low morale is pushing more workers to the exit ...
Bullish Sentiments for ImmunityBio (IBRX) After Trial Success and FDA Authorization
ImmunityBio, Inc. (NASDAQ:IBRX) is a clinical-stage immunotherapy company that develops next-generation therapies to treat ...
Is Your Meat Real or Lab-Grown? The USDA’s New Labeling Rules Aim to Make That Clear
This summer, the U.S. Department of Agriculture (USDA) is finalizing new national rules for labeling and marketing lab-grown ...
Hims & Hers’ ugly split with Wegovy maker weighs on the firm’s future
Hims & Hers, the high-flying online health company that rapidly grew from a buzzy startup selling Viagra to a multibillion-dollar business, had a hard month.
Budget cuts threaten the future of biomedical research—and the young scientists behind it
Over the last several months, a deep sense of unease has settled over laboratories across the United States. Researchers at ...
US FDA approves KalVista Pharma's swelling disorder drug, shares rise
KalVista Pharmaceuticals said on Monday the U.S. Food and Drug Administration has approved its drug, the first on-demand oral ...
Lexeo Therapeutics Receives Breakthrough Therapy Designation for Rare Disease Treatment
Lexeo Therapeutics received a breakthrough therapy designation from the Food and Drug Administration for its treatment for Friedreich's ataxia. Ataxia is a rare, inherited disease that damages the ...